Member Info for Jelenko

Regarding the NED's resignation, Brian is retiring and tbh wasn't a bundle of energy although very pleasant on the occasions we have met. Juliet was the finance background girl and both would have had to put themselves up for re election at the forthcoming AGM. so now is about the right time to leave.

I suspect the company no longer has the need for Juliet's expertise and they are eying up people with closer links to Big Pharma to take their place.

No big deal, only positives to have new blood with energy at some point.

30p realistic Lol. even 70p is not realistic Over 200p maybe. Clearly nobody on here realises what this technology is actually worth to a suitor. In the recent results video Andrew explained that one application could save or earn Astra Zeneca $2b extra per year so buying AGL below 200p no chance.

Just because the sp is 8p odd everyone forgets that not too long ago it was 167p !

There is a big difference between Isolating and harvesting. Cellsearch can Isolate but only Parsortix can Isolate and then harvest live viable CTC's.

Big Big difference.

They cannot issue shares below the nominal value of 10p, come on , wake up.

Carrot,

You are joking of course 60p to buy this IP is crazy, look the sp. now is pathetic and been trashed by uncertainty and MM's robbery. You can bet any bid will need to be close to £3 minimum for the board to even consider putting it to shareholders. That may sound odd now but only given how the ap. was trashed. It was 170p on FDA and has to go way above for a bid.

Well, CtDNA is only part. Angle specialise in CTC harvesting something that nobody else can do as yet. But from the same blood draw Angle can do both CTC and CTdna so not really competition. As far as CTC live harvesting Angle is the only game in town right now.

Rubbish absolute rubbish because the will not need to raise in the market at all and what will you be spouting about then when 2025 comes and goes LOL

Wrong! They have FDA approval for clinical use regarding Metastatic Breast Cancer

Don't think it is inevitable tbh

Very!

Actually that's not true because Parsortix can also analyse CTdna. And regarding the Prostate opportunity with Solaris, that does not require FDA approval because the tests will be carried out in certified labs also fee paying customers will avoid the reimbursement issue.

Come on guys do your research, Parsortix captures CtDNa if required and CTC's now I am no expert but I would rather analyse a living cell (CTC) than a dead one (CTC dna). Plus it can harvest and examine the live cells. I would say it's a no contest in favour of Parsortix and especially for big Pharma like AZN for drug development etc,

Not Really a good comparison They do not test blood. They use "stool" samples. and are totally lab based. They are trying to move into true liquid biopsy but yes their sp was pumped up to the sky. They find it hard to scale up without adding major costs. Unlike AGL who are aiming to provide the tools to customers and not do all the sampling. As in the goldrush it was the guys selling picks and shovels that made it big not the majority of prospectors.

I think you have forgotten the Abbott deal that is under discussion.

Actually, you cannot say that. I have read the email from Andrew Holder and all he said was the last fundraise was designed to cover the prostate trial recently announced. He did NOT say there would be a fundraise. Anything can happen and they could do a deal with Abbot that included a large ash element.

Hindesight talking

Mistake, Big mistake

CAGR is compound annual growth rate. Not sure where your 100% figure is from though.

Yes

The reagent that held up the ovarian is also used in the PCR covid test and as such there has been abnormal demand, the suppliers are limited because of the certification and quality control requirements for the labs that produce this so alternative suppliers are not found at the drop of a hat. I guess Angles order was sequestered by PCR test providers. Apparently it is being sorted.